Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling Small G Proteins Other

VH298, VHL inhibitor (ab230370)

Price and availability

23 452 ₸

Availability

Order now and get it on Thursday February 25, 2021

Key features and details

  • Potent, cell permeable VHL inhibitor
  • Purity: > 98%
  • 100 mM in DMSO

    100mM in ethanol

  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Anti-Sortilin/NT3 antibody (ab36959)
Product image
Anti-TEAD3 antibody (ab237766)
Product image
Recombinant Human Galectin 8/Gal-8 protein (ab99294)
Product image
Anti-Ifnb1 antibody - BSA and Azide free (Detector) (ab274352)

Overview

  • Product name

    VH298, VHL inhibitor
  • Description

    Potent, cell permeable VHL inhibitor
  • Biological description

    VH298 is a cell permeable compound that binds tightly to VHL (KD = 80- 90 nM in in vitro binding assays) leading to cellular accumulation of HIF1-α. VH298 selectively stabilizes hydroxylated HIF1-α and induces HIF-dependent transcription.

  • Purity

    > 98%
  • Chemical structure

    Chemical Structure

Properties

  • Chemical name

    (2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide

  • Molecular weight

    523.65
  • Molecular formula

    C27H33N5O4S
  • PubChem identifier

    122199236
  • Storage instructions

    Shipped at 4°C. Store at -20°C.
  • Solubility overview

    100 mM in DMSO

    100mM in ethanol

  • SMILES

    CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)C4(CC4)C#N)O
  • Source

    Synthetic

  • Research areas

    • Cell Biology
    • Cell Cycle
    • Cell Cycle Inhibitors
    • Other
    • Epigenetics and Nuclear Signaling
    • Transcription
    • Polymerase associated factors
    • Pol II Transcription
    • Cell Biology
    • Proteolysis / Ubiquitin
    • Proteasome / Ubiquitin
    • Proteasome
    • Cell Biology
    • Proteolysis / Ubiquitin
    • Proteasome / Ubiquitin
    • Ubiquitin
    • Cell Biology
    • Cell Cycle
    • Cell differentiation
    • Epigenetics and Nuclear Signaling
    • Transcription
    • Polymerase associated factors
    • Pol II Transcription
    • Other
    • Epigenetics and Nuclear Signaling
    • Transcription
    • Co-factors
    • Epigenetics and Nuclear Signaling
    • Transcription
    • Elongation factors
    • Cancer
    • Cell cycle
    • Cell differentiation
    • Cancer
    • Oncoproteins/suppressors
    • Tumor suppressors
    • Other
    • Cancer
    • Cancer Metabolism
    • Response to hypoxia
    • Metabolism
    • Pathways and Processes
    • Cofactors, Vitamins / minerals
    • Co-factors
    • Metabolism
    • Pathways and Processes
    • Metabolism processes
    • Hypoxia

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-p53 antibody [PAb 240] (ab26)

  •  
  • Product image

    Anti-C1r antibody (ab205546)

  •  
  • Product image

    Anti-Wnt10a antibody (ab189015)

  •  
  • Product image

    Anti-SHISA4 antibody (ab233400)

  •  
  • Product image

    Anti-FILIP1L antibody (ab122835)

  •  
  • Product image

    Anti-RNASEH2B antibody (ab122619)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.